Clinical and economic outcomes in the treatment of lower respiratory tract infections.

The American journal of managed care

Volumn 10, Issue 12 Suppl, 2004, Pages

  Brixner, Diana I ^a  

^a UNIVERSITY OF UTAH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; KETOLIDE;

ANTIBIOTIC RESISTANCE; BACTERIAL PNEUMONIA; CHRONIC BRONCHITIS; COMMUNICABLE DISEASE; ECONOMICS; HEALTH CARE COST; HUMAN; PHARMACOECONOMICS; RESPIRATORY TRACT INFECTION; REVIEW; TREATMENT OUTCOME;

ANTI-BACTERIAL AGENTS; BRONCHITIS, CHRONIC; COMMUNITY-ACQUIRED INFECTIONS; DRUG RESISTANCE, BACTERIAL; ECONOMICS, PHARMACEUTICAL; HEALTH CARE COSTS; HUMANS; KETOLIDES; PNEUMONIA, BACTERIAL; RESPIRATORY TRACT INFECTIONS; TREATMENT OUTCOME;

EID: 16644380682     PISSN: 10880224     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (34)